研究者
J-GLOBAL ID：202201008056852354   更新日: 2024年01月30日

郡山 弘

コオリヤマ ヒロシ | Koriyama Hiroshi
所属機関・部署：
大阪大学 医学部附属病院

大阪大学 医学部附属病院 について


競争的資金等の研究課題 (3件)：
  • 2016 - 2019 レニンアンジオテンシン系を標的としたワクチンの開発
  • 2015 - 2018 IL-17を標的としたDNAワクチンによる関節リウマチ骨破壊抑制治療の確立
  • 2014 - 2017 臨床応用を目指した高血圧症に対するワクチンの開発研究
論文 (38件)：
  • Hiroshi Koriyama, Yuka Ikeda, Hironori Nakagami, Munehisa Shimamura, Shota Yoshida, Hiromi Rakugi, Ryuichi Morishita. Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice. Vaccines. 2020. 8. 1
  • Akiko Tenma, Hironori Nakagami, Hideki Tomioka, Makoto Sakaguchi, Ryoko Ide, Hiroshi Koriyama, Hiroki Hayashi, Munehisa Shimamura, Hiromi Rakugi, Ryuichi Morishita. AJP001, a novel helper T-cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine. FASEB bioAdvances. 2019. 1. 12. 760-772
  • Tomohiro Kawano, Munehisa Shimamura, Hironori Nakagami, Tatsuya Iso, Hiroshi Koriyama, Shuko Takeda, Kosuke Baba, Tsutomu Sasaki, Manabu Sakaguchi, Ryuichi Morishita, et al. Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice. Hypertension (Dallas, Tex. : 1979). 2018. 72. 6. 1355-1364
  • Zhengda Pang, Akifumi Kushiyama, Jiao Sun, Takako Kikuchi, Hiroki Yamazaki, Yasuhiko Iwamoto, Hiroshi Koriyama, Shota Yoshida, Munehisa Shimamura, Masayoshi Higuchi, et al. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2017. 31. 9. 4053-4063
  • Kouji Wakayama, Munehisa Shimamura, Jun-Ichi Suzuki, Ryo Watanabe, Hiroshi Koriyama, Hiroshi Akazawa, Hironori Nakagami, Hideki Mochizuki, Mitsuaki Isobe, Ryuichi Morishita. Angiotensin II Peptide Vaccine Protects Ischemic Brain Through Reducing Oxidative Stress. Stroke. 2017. 48. 5. 1362-1368
もっと見る
MISC (16件)：
  • Hitomi Kurinami, Munehisa Shimamura, Hironori Nakagami, Hideo Shimizu, Hiroshi Koriyama, Tomohiro Kawano, Hideki Mochizuki, Ryuichi Morishita. Development of a Novel Anti-inflammatory and Anti-osteoplastic Peptide Based on De-loop and Ef-loop in Rankl for Treatment of Ischemic Stroke. STROKE. 2016. 47
  • 郡山 弘, 中神 啓徳, 勝谷 友宏, 楽木 宏実, 森下 竜一. アンジオテンシンIIワクチンによる高血圧症の新規治療法の開発. 日本高血圧学会総会プログラム・抄録集. 2015. 38回. 362-362
  • Hironori Nakagami, Hiroshi Koriyama, Ryuichi Morishita. Development of Therapeutic Vaccine for Angiotensin II. JOURNAL OF CARDIAC FAILURE. 2014. 20. 10. S151-S151
  • Hironori Nakagami, Mariana Kiomy Osako, Natsuki Yasumasa, Munehisa Shimamura, Mariko Kyutoku, Futoshi Nakagami, Hiroshi Koriyama, Hideki Tomioka, Tomohiro Katsuya, Ryuichi Morishita. Pitavastatin improves endothelial function and glucose metabolism in ovariectomized mice. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 2012. 12. 29-33
  • Mariko Kyutoku, Hironori Nakagami, Futoshi Nakagami, Hiroshi Koriyama, Mariana Kiomy Osako, Munehisa Shimamura, Takashi Miyake, Ryuichi Morishita. Lipoprotein(a) is a therapeutic target for cardiovascular disease. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry. 2012. 12. 118-121
もっと見る
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM